Niederer Kraft Frey advised the banking consortium led by Commerzbank Aktiengesellschaft, ING Bank, a branch of ING-DiBa AG, Landesbank Baden-Württemberg, Stuttgart, and UniCredit Bank AG acting as lenders, on term and multicurrency revolving credit
Tags :sx1
Credit Mutuel Equity is partnering with somnOO to support the expansion of their hotel portfolio and management platform. This includes providing growth capital and allowing somnOO’s management team to take a stake in the
Solör Bioenergy Group´s main shareholder, Nordic Infrastructure AG, successfully completed the first close of €215m Green Mezzanine Debt Facility. Solör Bioenergy Group is a leading energy company in the Nordics for wood-based
Credit Mutuel Equity is partnering with somnOO to support the expansion of their hotel portfolio and management platform. This includes providing growth capital and allowing somnOO’s management team to take a stake in the
VISCHER has advised DomoHealth SA on all corporate and contractual issues related to this financing round. The team was led by Maxime Chollet (partner, Corporate/M&A) with Basile Walder (managing associate, Corporate/M&
Berne-based LEM Surgical, an innovative company specializing in surgical robotics, has successfully completed its financing round B at the end of December 2023. CHF 22 million in funding have been secured from new investors from both the
Proteomedix, a Swiss private, commercial-stage diagnostics oncology company and Water Biotech are forming together a company called Onconetix. The transaction is implemented by the acquisition of Proteomedix for an all stock consideration. Onconetix’s commercial
Birgit Sambeth, partner at Altenburger and former President of the Swiss Bar Association, has been elected to the Board of Directors of Aéroport international de Genève (AIG), which plays a crucial role in
ams-OSRAM successfully completed its holistic financing plan, which consisted, among others, of a rights offering and the placement of high-yield bonds. In connec
Nasdaq-listed Altamira Therapeutics has successfully navigated a strategic repositioning with the assistance of legal counsel from Walder Wyss. The innovative move involved the sale of a 51% stake in its subsidiary, Altamira Medica, to a Swiss
